By Evonne Xu · 跨境并购 · 深度分析 · 约1500字
核心摘要
陈述与保证保险（Representations & Warranties Insurance，RWI）在过去五年已从北美并购市场的"可选配置"变成"标准配置"。但对于中国企业买方而言，RWI既是交易利器，也是认知陷阱。本文深度解析RWI的运作机制、真实理赔案例、以及中国买方最常踩的三个误区。
一、RWI是什么：一句话解释
在并购交易中，卖方需要在股权购买协议（SPA）中对目标公司的状况做出一系列"陈述与保证"——财务数据真实、没有重大未披露负债、知识产权权属清晰、没有重大诉讼等等。
如果这些陈述事后被证明不实，买方有权向卖方追偿。但问题在于：卖方在交易完成后往往已经将交易款项分配给了多个股东，追偿难度极大；私募基金作为卖方时，通常希望在交易完成后彻底"干净退出"，不愿承担任何追偿风险。
RWI保险的核心功能是：将卖方违反陈述与保证的赔偿责任，从卖方身上转移到保险公司身上。买方一旦发现陈述不实导致的损失，直接向保险公司理赔，无需追着卖方要钱。
二、RWI在中美跨境并购中的特殊价值
RWI在跨境交易中的价值，远超在纯美国本土交易中的价值，原因有三。
原因一：追偿路径更复杂
在纯美国交易中，买方和卖方都在美国司法管辖范围内，追偿相对直接。但在中美跨境并购中，如果卖方是中国实体，买方试图在中国法院执行美国仲裁裁决，面临的障碍是系统性的——中国法院对外国仲裁裁决的承认和执行存在高度不确定性。
RWI保险将追偿对象从中国卖方变成了美国保险公司，从根本上解决了跨境追偿难题。
原因二：尽职调查的局限性
跨境并购的尽职调查天然存在信息不对称。语言障碍、会计准则差异（中国GAAP vs. US GAAP）、监管披露要求不同，导致买方在尽调阶段很难发现目标公司的所有潜在问题。RWI保险为尽调遗漏提供了一道兜底保障。
原因三：竞争性报价中的战略优势
在竞争性拍卖流程中，提供"干净退出"的买方往往比坚持保留金或托管安排的买方更受卖方青睐。中国买方通过采用RWI，可以在报价结构上与欧美买方站在同一起跑线，提升交易竞争力。
三、RWI的运作机制：从投保到理赔
投保阶段
RWI保险通常在交易签约前2-4周启动投保流程。买方将尽职调查报告、SPA草案、目标公司财务数据提交给保险经纪人，由经纪人向多家承保保险公司征询报价。
保费通常为保额的2%-4%，保额通常设定为交易价值的10%-20%。以一笔$5,000万的并购交易为例，买方可能投保$500-1000万的保额，支付$15-40万的保费。
免赔额（Retention/Deductible）通常设定为交易价值的0.5%-1%，即买方需要自行承担前$25-50万的损失，超出部分才由保险公司赔付。
承保范围
标准RWI保单承保的风险包括：财务陈述不实（虚假财报、未披露负债）、税务风险、知识产权权属瑕疵、重大合同违约、环境合规问题、以及劳动法合规问题。
不承保的风险
同样重要的是了解RWI不承保什么：已知风险（尽调中已发现的问题）、前瞻性陈述（关于未来业绩的预测）、特定行业监管风险（如CFIUS审查结果）、以及欺诈性陈述（卖方故意欺骗的情形，但部分保单提供有限覆盖）。
理赔阶段
理赔触发条件是：买方发现某项陈述与保证在签约时即不实，且该不实导致了可量化的财务损失。买方需要向保险公司提交损失证明、不实陈述的具体内容、以及损失与陈述不实之间的因果关系证明。
理赔处理周期通常为3-12个月，复杂案件可能更长。
四、两起真实理赔案例
案例一：财务报表虚报（理赔成功）
某美国私募基金以$8,000万收购一家中型制造企业，采用RWI保险，保额$800万。交割后18个月，买方在整合过程中发现目标公司在收购前存在系统性的应收账款虚报，导致实际净资产比陈述低约$600万。
买方向RWI保险公司提交理赔，提供了审计底稿、前管理层邮件往来、以及第三方会计师出具的损失评估报告。保险公司在审查6个月后批准理赔，赔付$550万（扣除$50万免赔额）。
关键启示：书面证据链是理赔成功的核心。买方在整合阶段保存了完整的财务异常记录，是理赔获批的决定性因素。
案例二：知识产权权属争议（理赔部分成功）
某科技公司收购一家SaaS企业，RWI保额$500万。收购后，一名前员工提起诉讼，主张其在离职前开发的核心算法归其个人所有，而非目标公司所有。
RWI保险公司介入后发现：该前员工在雇用协议中确实未签署充分的IP转让条款，属于尽调阶段的遗漏。但由于该前员工的雇用协议在数据室中已有提供，保险公司主张买方在尽调阶段"应当知晓"该风险，属于"已知风险"范畴。
最终经过仲裁，保险公司承担了部分损失，但买方实际获赔金额仅为申请金额的40%。
关键启示：RWI不是尽调的替代品。尽调质量直接决定了理赔成功率。数据室中存在的文件，保险公司会认定买方"已知"。
五、中国买方最常踩的三个误区
误区一："有了RWI就不用认真做尽调"
这是最致命的误解。RWI保险的承保范围以尽调报告为基准——尽调中已发现或应当发现的风险，保险公司不赔。尽调做得越粗，保险公司的抗辩理由越充分。
误区二："RWI保额越高越好"
保额需要与风险敞口匹配，盲目提高保额只会增加保费支出。正确的做法是：基于尽调发现的具体风险点，与保险经纪人共同测算合理保额，而非简单地将保额设定为交易价值的固定百分比。
误区三："RWI可以覆盖所有并购风险"
RWI只覆盖陈述与保证违反的风险。商业风险（市场萎缩、客户流失、竞争加剧）、整合风险（管理团队流失、文化冲突）、以及监管风险（CFIUS审查、反垄断审查）均不在RWI承保范围内。将RWI视为并购风险的"全险"是一个代价高昂的误解。
六、结语：RWI是工具，不是答案
RWI保险在中美跨境并购中是真实有效的风险转移工具，但它的价值建立在高质量尽职调查的基础之上。没有扎实的尽调，RWI不过是一张覆盖范围模糊的昂贵保单。
最好的并购保护，永远是在交割前把问题找出来，而不是在交割后找保险公司理赔。RWI的正确定位是：尽调之后的最后一道防线，而不是尽调的替代品。
关于作者
Evonne Xu 是一位专注于中美跨境并购与AI法律合规的律师，同时也是法律科技工具的构建者。
📩 订阅每周AI法律简报：evonnexulegal.beehiiv.com/subscribe 📅 预约一对一咨询：evonnexulegal.com/#contact
RWI Insurance in Cross-Border M&A: Your Strongest Shield or an Expensive Placebo?
By Evonne Xu · Cross-Border M&A · Deep Analysis · ~1500 words
Executive Summary
Representations and Warranties Insurance (RWI) has evolved from an optional feature to a standard fixture in North American M&A over the past five years. For Chinese acquirers, however, RWI is both a powerful deal tool and a source of costly misconceptions. This article provides a deep analysis of how RWI works, real claims cases, and the three most common mistakes Chinese buyers make.
I. What RWI Is: One-Sentence Explanation
In an M&A transaction, sellers make a series of representations and warranties in the Stock Purchase Agreement (SPA) about the target company's condition — that financial data is accurate, that there are no material undisclosed liabilities, that intellectual property ownership is clear, that there is no material litigation, and so on.
If these representations prove to be false, the buyer has the right to seek indemnification from the seller. The problem: by the time a breach is discovered, sellers have typically distributed deal proceeds across multiple shareholders, making recovery extremely difficult. Private equity sellers in particular want a clean exit after closing, with no residual indemnification exposure.
RWI insurance transfers the seller's indemnification liability for breaches of representations and warranties to an insurance company. When the buyer discovers losses from a misrepresentation, they claim directly against the insurer — no need to chase the seller.
II. The Special Value of RWI in U.S.-China Cross-Border M&A
RWI delivers even greater value in cross-border transactions than in purely domestic U.S. deals, for three reasons.
Reason one: Recovery pathways are more complex
In purely domestic U.S. transactions, both buyer and seller fall within U.S. jurisdiction, and recovery is relatively straightforward. In U.S.-China cross-border M&A, if the seller is a Chinese entity, a buyer attempting to enforce a U.S. arbitration award in Chinese courts faces systemic obstacles — Chinese courts apply highly uncertain standards when recognizing and enforcing foreign arbitral awards.
RWI transforms the recovery counterparty from a Chinese seller to a U.S. insurance company, fundamentally resolving the cross-border enforcement problem.
Reason two: The inherent limitations of due diligence
Cross-border due diligence carries structural information asymmetry. Language barriers, accounting standard differences (Chinese GAAP vs. U.S. GAAP), and different regulatory disclosure requirements make it genuinely difficult for buyers to surface every potential issue during diligence. RWI provides a backstop for diligence gaps.
Reason three: Strategic advantage in competitive processes
In competitive auction processes, buyers offering sellers a clean exit are typically preferred over those insisting on holdbacks or escrow arrangements. By adopting RWI, Chinese buyers can compete on deal structure terms with European and American bidders, improving their overall competitiveness.
III. How RWI Works: From Underwriting to Claims
Underwriting
The RWI underwriting process typically begins two to four weeks before signing. The buyer submits due diligence reports, a draft SPA, and target company financial data to an insurance broker, who solicits quotes from multiple underwriters.
Premiums typically run 2%–4% of the policy limit. Coverage limits are typically set at 10%–20% of deal value. For a $50 million acquisition, a buyer might purchase $5–10 million in coverage for $150,000–$400,000 in premium.
The retention (deductible) is typically set at 0.5%–1% of deal value, meaning the buyer absorbs the first $250,000–$500,000 in losses before the insurer pays.
Coverage
Standard RWI policies cover: financial misrepresentations (false financials, undisclosed liabilities), tax exposure, IP ownership defects, material contract breaches, environmental compliance issues, and labor law compliance.
Exclusions
Equally important is what RWI does not cover: known risks (issues identified in due diligence), forward-looking statements (projections about future performance), certain regulatory risks (such as CFIUS review outcomes), and fraudulent misrepresentation by the seller (though some policies offer limited coverage).
Claims
A claim is triggered when the buyer discovers that a representation or warranty was false as of the signing date and that the misrepresentation caused a quantifiable financial loss. The buyer must submit proof of loss, the specific misrepresentation, and evidence of causation. Claims processing typically takes three to twelve months, longer for complex cases.
IV. Two Real Claims Cases
Case one: Financial statement misrepresentation (successful claim)
A U.S. private equity fund acquired a mid-size manufacturing company for $80 million with RWI coverage of $8 million. Eighteen months post-closing, during integration, the buyer discovered systematic accounts receivable inflation predating the acquisition, resulting in net assets approximately $6 million below the represented amount.
The buyer submitted a claim supported by audit workpapers, former management email correspondence, and a third-party accountant's loss assessment. After six months of review, the insurer approved a payment of $5.5 million (after a $500,000 retention). Key takeaway: documentation is decisive. The buyer's comprehensive records of financial anomalies discovered during integration were the determining factor in the successful claim.
Case two: IP ownership dispute (partial recovery)
A technology company acquired a SaaS business with $5 million in RWI coverage. Post-closing, a former employee filed suit claiming that a core algorithm developed before his departure was his personal property, not the target company's. The insurer found that the former employee's employment agreement had not included adequate IP assignment provisions — a due diligence gap. However, because the employment agreement had been available in the data room, the insurer argued the buyer "should have known" the risk, classifying it as a known risk. After arbitration, the insurer covered a portion of the loss, but the buyer recovered only 40% of the claimed amount.
Key takeaway: RWI is not a substitute for due diligence. Documents in the data room are presumed known to the buyer. Diligence quality directly determines claims success.
V. The Three Most Common Mistakes Chinese Buyers Make
Mistake one: "With RWI, we don't need to invest in serious due diligence"
This is the most costly misconception. RWI coverage is benchmarked against the due diligence report — risks identified or identifiable in diligence are excluded. The lower the quality of diligence, the stronger the insurer's grounds for denial.
Mistake two: "Higher coverage limits are always better"
Coverage limits need to match actual risk exposure. Blindly maximizing limits only increases premium spend. The correct approach: work with an insurance broker to model appropriate limits based on the specific risk points identified in diligence, rather than applying a fixed percentage of deal value.
Mistake three: "RWI covers all M&A risk"
RWI covers only breaches of representations and warranties. Commercial risks (market contraction, customer loss, competitive pressure), integration risks (management departure, cultural conflict), and regulatory risks (CFIUS review, antitrust clearance) all fall outside RWI coverage. Treating RWI as comprehensive deal insurance is a misconception with a high price tag.
VI. Conclusion: RWI Is a Tool, Not an Answer
RWI insurance is a genuinely effective risk transfer tool in U.S.-China cross-border M&A — but its value is built on a foundation of high-quality due diligence. Without rigorous diligence, RWI is an expensive policy with uncertain coverage.
The best protection in any acquisition is finding the problems before closing, not filing claims after. RWI's proper role is as the last line of defense after thorough due diligence — not a replacement for it.
About the Author
Evonne Xu is an attorney specializing in U.S.-China cross-border M&A and AI legal compliance, and a builder of legal tech tools.
📩 Subscribe to the weekly AI law brief: evonnexulegal.beehiiv.com/subscribe 📅 Book a consultation: evonnexulegal.com/#contact